NY-ESO-1 is a Ubiquitous Immunotherapeutic Target Antigen for Patients with Myxoid/ Round Cell Liposarcoma

BACKGROUND: Myxoid/ round cell liposarcoma (MRCL) is the second most common liposarcoma subtype, accounting for more than one third of liposarcomas and approximately 10% of all soft tissue sarcomas. Although MRCL is a chemosensitive subtype, patients with metastatic disease have a poor outcome. NY-E...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pollack, Seth M., Jungbluth, Achim A., Hoch, Benjamin L., Farrar, Erik A., Bleakley, Marie, Schneider, David J., Loggers, Elizabeth T., Rodler, Eve, Eary, Janet F., Conrad, Ernest U., Jones, Robin L., Yee, Cassian
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361576/
https://ncbi.nlm.nih.gov/pubmed/22359263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27446
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker